Published February 27, 2020
NEW FDA COMMISSIONER DR. STEPHEN HAHN HIGHLIGHTS VALUE OF CBD IN FIRST PUBLIC COMMENTS, SAYS “…CERTAINLY AMERICANS THINK THAT’S THE CASE”
Today, we are very pleased that the FDA listened — and are grateful that Commissioner Hahn and the FDA continue to share our industry’s commitment to help farmers farm this versatile crop and provide global access to reliable and compliant food grade hemp-derived products.
Yesterday (2/26), Commissioner Hahn gave his first public speech at the NASDA Winter Policy Conference where he pointedly addressed the topic of hemp-derived CBD products and acknowledged their real value, market demand, and the need for swift regulatory clarity and standards.
Commissioner Hahn was very specific in his comments, saying, “…People are using these products. We’re not going to be able to say you can’t use these products. Even if we did, it’s a fool’s game to even try to approach that.” Citing current hemp-derived products currently approved by FDA and in market, Hahn noted, “…CBD is the active ingredient in that. And that is really, I think, life saving for these kids with these awful seizure disorders.”
This messaging from FDA leadership signifies a recognition of the value of hemp and its derivative products by federal legislators, an advancement from FDA’s previous position. The statement further reinforces the importance for enforceable consumer protection standards — like the international food-grade compliance standards, farming accreditations, and manufacturing best practices that IsolatePureCBD was founded on.
“Hemp is food,” said IsolatePureCBD CEO, “Legalization is not a smooth path, but we (IsolatePureCBD) have been here since before Day 1, and will continue to find legal ways to provide the public with access to high quality cannabinoid products from our farming partners.”
Fortune favors the bold, and we at IsolatePureCBD remain dedicated to forwarding this mission and advancing its progress every day.
